2018 Q4 Form 10-K Financial Statement

#000143774919005894 Filed on March 28, 2019

View on sec.gov

Income Statement

Concept 2018 Q4 2018 2017 Q4
Revenue $2.980M $10.28M $2.080M
YoY Change 43.27% 49.75% 47.52%
Cost Of Revenue $1.100M $3.847M $870.0K
YoY Change 26.44% 36.23% 70.59%
Gross Profit $1.880M $6.429M $1.210M
YoY Change 55.37% 59.21% 34.44%
Gross Profit Margin 63.09% 62.56% 58.17%
Selling, General & Admin $580.0K $2.716M $600.0K
YoY Change -3.33% 3.47% -1.64%
% of Gross Profit 30.85% 42.25% 49.59%
Research & Development $410.0K $1.237M $370.0K
YoY Change 10.81% -42.78% -37.29%
% of Gross Profit 21.81% 19.24% 30.58%
Depreciation & Amortization $30.00K $133.0K $50.00K
YoY Change -40.0% -35.44% -28.57%
% of Gross Profit 1.6% 2.07% 4.13%
Operating Expenses $990.0K $3.953M $970.0K
YoY Change 2.06% -17.42% -19.17%
Operating Profit $890.0K $2.476M $240.0K
YoY Change 270.83% -430.57% -180.0%
Interest Expense -$50.00K $189.0K -$50.00K
YoY Change 0.0% -190.43% 25.0%
% of Operating Profit -5.62% 7.63% -20.83%
Other Income/Expense, Net $0.00 $0.00
YoY Change
Pretax Income $850.0K $2.287M $190.0K
YoY Change 347.37% -7723.33% -155.88%
Income Tax
% Of Pretax Income
Net Earnings $850.0K $2.287M $190.0K
YoY Change 347.37% -7723.33% -155.88%
Net Earnings / Revenue 28.52% 22.26% 9.13%
Basic Earnings Per Share $0.16
Diluted Earnings Per Share $54.66K $0.14 $14.62K
COMMON SHARES
Basic Shares Outstanding 13.05M
Diluted Shares Outstanding 15.06M

Balance Sheet

Concept 2018 Q4 2018 2017 Q4
SHORT-TERM ASSETS
Cash & Short-Term Investments $1.700M $1.700M $200.0K
YoY Change 750.0% 750.0% 100.0%
Cash & Equivalents $1.652M $1.700M $224.0K
Short-Term Investments
Other Short-Term Assets $100.0K $100.0K $100.0K
YoY Change 0.0% 0.0% 0.0%
Inventory $0.00 $15.00K
Prepaid Expenses $91.00K $89.00K
Receivables $1.967M $2.000M $962.0K
Other Receivables $0.00 $0.00 $0.00
Total Short-Term Assets $3.710M $3.700M $1.290M
YoY Change 187.6% 184.62% 38.86%
LONG-TERM ASSETS
Property, Plant & Equipment $200.0K $300.0K $124.0K
YoY Change 61.29% 200.0% -59.74%
Goodwill
YoY Change
Intangibles
YoY Change
Long-Term Investments
YoY Change
Other Assets $38.00K $0.00 $38.00K
YoY Change 0.0% -5.0%
Total Long-Term Assets $359.0K $400.0K $162.0K
YoY Change 121.6% 100.0% -53.45%
TOTAL ASSETS
Total Short-Term Assets $3.710M $3.700M $1.290M
Total Long-Term Assets $359.0K $400.0K $162.0K
Total Assets $4.069M $4.100M $1.452M
YoY Change 180.23% 173.33% 13.7%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $193.0K $200.0K $194.0K
YoY Change -0.52% 0.0% -5.37%
Accrued Expenses $1.403M $1.400M $988.0K
YoY Change 42.0% 40.0% 42.98%
Deferred Revenue $1.004M $406.0K
YoY Change 147.29%
Short-Term Debt $0.00 $0.00 $0.00
YoY Change
Long-Term Debt Due $100.0K $100.0K $0.00
YoY Change -100.0%
Total Short-Term Liabilities $3.252M $3.300M $2.079M
YoY Change 56.42% 57.14% 19.97%
LONG-TERM LIABILITIES
Long-Term Debt $1.900M $1.900M $2.900M
YoY Change -34.48% -34.48% 0.0%
Other Long-Term Liabilities
YoY Change
Total Long-Term Liabilities $1.879M $1.900M $2.900M
YoY Change -35.21% -34.48% 0.0%
TOTAL LIABILITIES
Total Short-Term Liabilities $3.252M $3.300M $2.079M
Total Long-Term Liabilities $1.879M $1.900M $2.900M
Total Liabilities $5.131M $5.100M $5.000M
YoY Change 2.62% 2.0% 6.38%
SHAREHOLDERS EQUITY
Retained Earnings -$59.24M -$61.53M
YoY Change -3.72% 0.05%
Common Stock $133.0K $128.0K
YoY Change 3.91% 0.0%
Preferred Stock
YoY Change
Treasury Stock (at cost) $362.0K $362.0K
YoY Change 0.0% 0.0%
Treasury Stock Shares $10.00K $10.00K
Shareholders Equity -$1.062M -$1.100M -$3.509M
YoY Change
Total Liabilities & Shareholders Equity $4.069M $4.100M $1.452M
YoY Change 180.23% 173.33% 13.7%

Cashflow Statement

Concept 2018 Q4 2018 2017 Q4
OPERATING ACTIVITIES
Net Income $850.0K $2.287M $190.0K
YoY Change 347.37% -7723.33% -155.88%
Depreciation, Depletion And Amortization $30.00K $133.0K $50.00K
YoY Change -40.0% -35.44% -28.57%
Cash From Operating Activities $790.0K $2.578M $0.00
YoY Change 847.79% -100.0%
INVESTING ACTIVITIES
Capital Expenditures -$30.00K $202.0K -$10.00K
YoY Change 200.0% 910.0% 0.0%
Acquisitions
YoY Change
Other Investing Activities $0.00 $0.00 $0.00
YoY Change -100.0%
Cash From Investing Activities -$30.00K -$202.0K $0.00
YoY Change -661.11% -100.0%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities 40.00K -948.0K -30.00K
YoY Change -233.33% 540.54% -106.12%
NET CHANGE
Cash From Operating Activities 790.0K 2.578M 0.000
Cash From Investing Activities -30.00K -202.0K 0.000
Cash From Financing Activities 40.00K -948.0K -30.00K
Net Change In Cash 800.0K 1.428M -30.00K
YoY Change -2766.67% 792.5% -80.0%
FREE CASH FLOW
Cash From Operating Activities $790.0K $2.578M $0.00
Capital Expenditures -$30.00K $202.0K -$10.00K
Free Cash Flow $820.0K $2.376M $10.00K
YoY Change 8100.0% 842.86% -101.61%

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
CY2018 dei Amendment Flag
AmendmentFlag
false
CY2018 dei Document Fiscal Period Focus
DocumentFiscalPeriodFocus
FY
CY2018 dei Document Fiscal Year Focus
DocumentFiscalYearFocus
2018
CY2018 dei Document Period End Date
DocumentPeriodEndDate
2018-12-31
CY2018 dei Document Type
DocumentType
10-K
CY2018Q2 dei Entity Public Float
EntityPublicFloat
15043000
CY2018 dei Entity Shell Company
EntityShellCompany
false
CY2018Q4 intz Capital Leases Future Minimum Payments Due In Four Years And Thereafter
CapitalLeasesFutureMinimumPaymentsDueInFourYearsAndThereafter
CY2018 intz Defined Contribution Plan Minimum Age Required For Contribution Of Additional Amount Of Salary Per Year
DefinedContributionPlanMinimumAgeRequiredForContributionOfAdditionalAmountOfSalaryPerYear
P50Y
CY2018 intz Effective Income Tax Rate Reconciliation Remeasurement Of Deferred Taxes
EffectiveIncomeTaxRateReconciliationRemeasurementOfDeferredTaxes
CY2017 intz Effective Income Tax Rate Reconciliation Remeasurement Of Deferred Taxes
EffectiveIncomeTaxRateReconciliationRemeasurementOfDeferredTaxes
11476000
CY2018 intz Extinguishment Of Uk Cumulative Translation
ExtinguishmentOfUkCumulativeTranslation
64000
CY2017 intz Extinguishment Of Uk Cumulative Translation
ExtinguishmentOfUkCumulativeTranslation
CY2018 intz Number Of Major United States Financial Institutions
NumberOfMajorUnitedStatesFinancialInstitutions
2
CY2018 intz Number Of Operating Leases
NumberOfOperatingLeases
2
CY2018Q4 intz Number Of Stockbased Compensation Plans
NumberOfStockbasedCompensationPlans
2
CY2018Q4 intz Operating Leases Future Minimum Payments Due In Three Years And Thereafter
OperatingLeasesFutureMinimumPaymentsDueInThreeYearsAndThereafter
1100000
CY2018 intz Penalties And Waived Penalties On Dividends
PenaltiesAndWaivedPenaltiesOnDividends
47000
CY2017 intz Penalties And Waived Penalties On Dividends
PenaltiesAndWaivedPenaltiesOnDividends
33000
CY2018 intz Period Of Payment Terms Offered To Customers Distributions And Resellers Domestically
PeriodOfPaymentTermsOfferedToCustomersDistributionsAndResellersDomestically
P30D
CY2018 intz Period Of Payment Terms Offered To Customers Distributors And Resllers Internationally
PeriodOfPaymentTermsOfferedToCustomersDistributorsAndResllersInternationally
P45D
CY2018 intz Sharebased Compensation Arrangement By Sharebased Payment Award Award Exercisable Period1
SharebasedCompensationArrangementBySharebasedPaymentAwardAwardExercisablePeriod1
P1Y
CY2018 intz Sharebased Compensation Arrangement By Sharebased Payment Award Award Exercisable Period2
SharebasedCompensationArrangementBySharebasedPaymentAwardAwardExercisablePeriod2
P3Y
CY2018 intz Sharebased Compensation Arrangement By Sharebased Payment Award Award Exercisable Period3
SharebasedCompensationArrangementBySharebasedPaymentAwardAwardExercisablePeriod3
P5Y
CY2018 intz Sharebased Compensation Arrangement By Sharebased Payment Award Options Grants In Period Gross At Price Equal To Market Value
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsGrantsInPeriodGrossAtPriceEqualToMarketValue
24000
CY2017 intz Sharebased Compensation Arrangement By Sharebased Payment Award Options Grants In Period Gross At Price Equal To Market Value
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsGrantsInPeriodGrossAtPriceEqualToMarketValue
24000
CY2018 intz Sharebased Compensation Arrangement By Sharebased Payment Award Options Grants In Period Gross At Price Greater Than Market Value
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsGrantsInPeriodGrossAtPriceGreaterThanMarketValue
CY2017 intz Sharebased Compensation Arrangement By Sharebased Payment Award Options Grants In Period Gross At Price Greater Than Market Value
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsGrantsInPeriodGrossAtPriceGreaterThanMarketValue
CY2018 intz Sharebased Compensation Arrangements By Sharebased Payment Award Options Expiration Term For Options Granted To Holders Of More Than Specified Percentage Of Voting Stock
SharebasedCompensationArrangementsBySharebasedPaymentAwardOptionsExpirationTermForOptionsGrantedToHoldersOfMoreThanSpecifiedPercentageOfVotingStock
P5Y
CY2018 intz Sharebased Compensation Arrangements By Sharebased Payment Award Options Grants In Period Weighted Average Exercise Price Equal To Market Value
SharebasedCompensationArrangementsBySharebasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePriceEqualToMarketValue
1.15
CY2017 intz Sharebased Compensation Arrangements By Sharebased Payment Award Options Grants In Period Weighted Average Exercise Price Equal To Market Value
SharebasedCompensationArrangementsBySharebasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePriceEqualToMarketValue
0.42
CY2018 intz Sharebased Compensation Arrangements By Sharebased Payment Award Options Grants In Period Weighted Average Exercise Price Greater Than Market Value
SharebasedCompensationArrangementsBySharebasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePriceGreaterThanMarketValue
CY2017 intz Sharebased Compensation Arrangements By Sharebased Payment Award Options Grants In Period Weighted Average Exercise Price Greater Than Market Value
SharebasedCompensationArrangementsBySharebasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePriceGreaterThanMarketValue
CY2018Q4 us-gaap Accounts Payable Current
AccountsPayableCurrent
193000
CY2017Q4 us-gaap Accounts Payable Current
AccountsPayableCurrent
194000
CY2018Q4 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
1967000
CY2017Q4 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
962000
CY2018Q4 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
1403000
CY2017Q4 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
988000
CY2018Q4 us-gaap Accrued Rent Current
AccruedRentCurrent
191000
CY2017Q4 us-gaap Accrued Rent Current
AccruedRentCurrent
139000
CY2018Q4 us-gaap Accrued Salaries Current
AccruedSalariesCurrent
154000
CY2017Q4 us-gaap Accrued Salaries Current
AccruedSalariesCurrent
131000
CY2018Q4 us-gaap Accrued Vacation Current
AccruedVacationCurrent
310000
CY2017Q4 us-gaap Accrued Vacation Current
AccruedVacationCurrent
284000
CY2018Q4 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
1828000
CY2017Q4 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
1695000
CY2018Q4 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
-43000
CY2017Q4 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
-107000
CY2018Q4 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
56609000
CY2017Q4 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
56518000
CY2018Q4 us-gaap Allowance For Doubtful Accounts Receivable
AllowanceForDoubtfulAccountsReceivable
0
CY2017Q4 us-gaap Allowance For Doubtful Accounts Receivable
AllowanceForDoubtfulAccountsReceivable
0
CY2018 us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
0
CY2017 us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
2941861
CY2018Q4 us-gaap Assets
Assets
4069000
CY2017Q4 us-gaap Assets
Assets
1452000
CY2018Q4 us-gaap Assets Current
AssetsCurrent
3710000
CY2017Q4 us-gaap Assets Current
AssetsCurrent
1290000
CY2018 us-gaap Capital Expenditures Incurred But Not Yet Paid
CapitalExpendituresIncurredButNotYetPaid
128000
CY2017 us-gaap Capital Expenditures Incurred But Not Yet Paid
CapitalExpendituresIncurredButNotYetPaid
CY2018Q4 us-gaap Capital Lease Obligations
CapitalLeaseObligations
128000
CY2018Q4 us-gaap Capital Lease Obligations Current
CapitalLeaseObligationsCurrent
58000
CY2017Q4 us-gaap Capital Lease Obligations Current
CapitalLeaseObligationsCurrent
44000
CY2018Q4 us-gaap Capital Lease Obligations Noncurrent
CapitalLeaseObligationsNoncurrent
64000
CY2017Q4 us-gaap Capital Lease Obligations Noncurrent
CapitalLeaseObligationsNoncurrent
17000
CY2018Q4 us-gaap Capital Leases Future Minimum Payments Due
CapitalLeasesFutureMinimumPaymentsDue
122000
CY2018Q4 us-gaap Capital Leases Future Minimum Payments Due Current
CapitalLeasesFutureMinimumPaymentsDueCurrent
62000
CY2018Q4 us-gaap Capital Leases Future Minimum Payments Due In Three Years
CapitalLeasesFutureMinimumPaymentsDueInThreeYears
21000
CY2018Q4 us-gaap Capital Leases Future Minimum Payments Due In Two Years
CapitalLeasesFutureMinimumPaymentsDueInTwoYears
45000
CY2018Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
1652000
CY2017Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
224000
CY2016Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
64000
CY2018 us-gaap Cash And Cash Equivalents Period Increase Decrease
CashAndCashEquivalentsPeriodIncreaseDecrease
1428000
CY2017 us-gaap Cash And Cash Equivalents Period Increase Decrease
CashAndCashEquivalentsPeriodIncreaseDecrease
160000
CY2018Q4 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
CY2017Q4 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
CY2018Q4 us-gaap Common Stock Capital Shares Reserved For Future Issuance
CommonStockCapitalSharesReservedForFutureIssuance
2785042
CY2018Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.01
CY2017Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.01
CY2018Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
80000000
CY2017Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
80000000
CY2018Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
13259000
CY2017Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
12808000
CY2018Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
13249000
CY2017Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
12798000
CY2018Q4 us-gaap Common Stock Value
CommonStockValue
133000
CY2017Q4 us-gaap Common Stock Value
CommonStockValue
128000
CY2018 us-gaap Concentration Risk Credit Risk
ConcentrationRiskCreditRisk
<div style="display: inline; font-family: times new roman; font-size: 10pt"><div style="display: inline; font-family: times new roman; font-size: 10pt"><div style="display: inline; font-family: times new roman; font-size: 10pt"><div style=" font-family:'Times New Roman', Times, serif;font-size:10pt;margin-bottom:0pt;margin-left:36pt;margin-right:0pt;margin-top:0pt;text-align:left;text-indent:-36pt;"><div style="display: inline; font-style: italic;"><div style="display: inline; font-weight: bold;">Risk Concentration</div></div></div> <div style=" font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:left;">&nbsp;</div> <div style=" font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:left;text-indent:36pt;">Financial instruments, which potentially subject us to concentrations of credit risk, are primarily cash and cash equivalents, investments and accounts receivable. Cash and cash equivalent deposits are at risk to the extent that they exceed Federal Deposit Insurance Corporation insured amounts. To minimize risk, we place our investments in U.S. government obligations, corporate securities and money market funds. Substantially all of our cash, cash equivalents and investments are maintained with <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">two</div> major U.S. financial institutions. We do <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">not</div> believe that we are subject to any unusual financial risk with our banking arrangements. We have <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">not</div> experienced any significant losses on our cash and cash equivalents.</div> <div style=" font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:left;">&nbsp;</div> <div style=" font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:left;text-indent:36pt;">We sell our products to customers primarily in the United States. In the future, we <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"> may </div>sale our products internationally. Fluctuations in currency exchange rates and adverse economic developments in foreign countries could adversely affect the Company&#x2019;s operating results. We perform ongoing credit evaluations of our customers&#x2019; financial condition and generally require <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">no</div> collateral. We maintain reserves for potential credit losses, and such losses, in the aggregate, have historically been minimal.</div></div></div></div>
CY2018Q4 us-gaap Contract With Customer Asset Net Current
ContractWithCustomerAssetNetCurrent
1967000
CY2017Q4 us-gaap Contract With Customer Asset Net Current
ContractWithCustomerAssetNetCurrent
962000
CY2018Q4 us-gaap Contract With Customer Liability Current
ContractWithCustomerLiabilityCurrent
1004000
CY2017Q4 us-gaap Contract With Customer Liability Current
ContractWithCustomerLiabilityCurrent
406000
CY2018 us-gaap Cost Of Goods And Services Sold
CostOfGoodsAndServicesSold
3847000
CY2017 us-gaap Cost Of Goods And Services Sold
CostOfGoodsAndServicesSold
2824000
CY2018Q4 us-gaap Deferred Tax Assets Gross
DeferredTaxAssetsGross
21204000
CY2017Q4 us-gaap Deferred Tax Assets Gross
DeferredTaxAssetsGross
21654000
CY2018Q4 us-gaap Deferred Tax Assets Liabilities Net
DeferredTaxAssetsLiabilitiesNet
CY2017Q4 us-gaap Deferred Tax Assets Liabilities Net
DeferredTaxAssetsLiabilitiesNet
CY2018Q4 us-gaap Deferred Tax Assets Operating Loss Carryforwards
DeferredTaxAssetsOperatingLossCarryforwards
20720000
CY2017Q4 us-gaap Deferred Tax Assets Operating Loss Carryforwards
DeferredTaxAssetsOperatingLossCarryforwards
21175000
CY2018Q4 us-gaap Deferred Tax Assets Operating Loss Carryforwards Foreign
DeferredTaxAssetsOperatingLossCarryforwardsForeign
374000
CY2017Q4 us-gaap Deferred Tax Assets Operating Loss Carryforwards Foreign
DeferredTaxAssetsOperatingLossCarryforwardsForeign
374000
CY2018Q4 us-gaap Deferred Tax Assets Other
DeferredTaxAssetsOther
78000
CY2017Q4 us-gaap Deferred Tax Assets Other
DeferredTaxAssetsOther
94000
CY2018Q4 us-gaap Deferred Tax Assets Property Plant And Equipment
DeferredTaxAssetsPropertyPlantAndEquipment
4000
CY2018Q4 us-gaap Deferred Tax Assets Tax Deferred Expense Compensation And Benefits Share Based Compensation Cost
DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost
28000
CY2017Q4 us-gaap Deferred Tax Assets Tax Deferred Expense Compensation And Benefits Share Based Compensation Cost
DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost
25000
CY2018Q4 us-gaap Deferred Tax Assets Valuation Allowance
DeferredTaxAssetsValuationAllowance
21204000
CY2017Q4 us-gaap Deferred Tax Assets Valuation Allowance
DeferredTaxAssetsValuationAllowance
21654000
CY2017Q4 us-gaap Deferred Tax Liabilities Property Plant And Equipment
DeferredTaxLiabilitiesPropertyPlantAndEquipment
14000
CY2018 us-gaap Defined Contribution Plan Cost Recognized
DefinedContributionPlanCostRecognized
30000
CY2017 us-gaap Defined Contribution Plan Cost Recognized
DefinedContributionPlanCostRecognized
30000
CY2018 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.14
CY2017 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.01
CY2018Q4 us-gaap Dividends Payable Current
DividendsPayableCurrent
594000
CY2017Q4 us-gaap Dividends Payable Current
DividendsPayableCurrent
447000
CY2018Q4 us-gaap Dividends Payable Current And Noncurrent
DividendsPayableCurrentAndNoncurrent
139000
CY2017Q4 us-gaap Dividends Payable Current And Noncurrent
DividendsPayableCurrentAndNoncurrent
139000
CY2018 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.16
CY2017 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.01
CY2018 us-gaap Defined Contribution Plan Employer Matching Contribution Percent
DefinedContributionPlanEmployerMatchingContributionPercent
0.04
CY2018 us-gaap Defined Contribution Plan Employer Matching Contribution Percent Of Match
DefinedContributionPlanEmployerMatchingContributionPercentOfMatch
0.0025
CY2018 us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
133000
CY2017 us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
206000
CY2017 us-gaap Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate
EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate
0.39
CY2018 us-gaap Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate
EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate
0.21
CY2018 us-gaap Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized Period For Recognition1
EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1
P1Y3D
CY2018Q4 us-gaap Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized Stock Options
EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions
16000
CY2018Q4 us-gaap Furniture And Fixtures Gross
FurnitureAndFixturesGross
43000
CY2017Q4 us-gaap Furniture And Fixtures Gross
FurnitureAndFixturesGross
43000
CY2018 us-gaap Gain On Sale Of Investments
GainOnSaleOfInvestments
CY2017 us-gaap Gain On Sale Of Investments
GainOnSaleOfInvestments
56000
CY2018 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
1112000
CY2017 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
1094000
CY2018 us-gaap Gross Profit
GrossProfit
6429000
CY2017 us-gaap Gross Profit
GrossProfit
4038000
CY2018 us-gaap Impairment Of Long Lived Assets Held For Use
ImpairmentOfLongLivedAssetsHeldForUse
0
CY2017 us-gaap Impairment Of Long Lived Assets Held For Use
ImpairmentOfLongLivedAssetsHeldForUse
0
CY2018 us-gaap Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments
IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments
2287000
CY2017 us-gaap Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments
IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments
-30000
CY2018Q4 us-gaap Income Tax Examination Penalties And Interest Accrued
IncomeTaxExaminationPenaltiesAndInterestAccrued
0
CY2017Q4 us-gaap Income Tax Examination Penalties And Interest Accrued
IncomeTaxExaminationPenaltiesAndInterestAccrued
0
CY2018 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
CY2017 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
CY2018 us-gaap Income Tax Reconciliation Change In Deferred Tax Assets Valuation Allowance
IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance
-450000
CY2017 us-gaap Income Tax Reconciliation Change In Deferred Tax Assets Valuation Allowance
IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance
-11478000
CY2018 us-gaap Income Tax Reconciliation Income Tax Expense Benefit At Federal Statutory Income Tax Rate
IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate
480000
CY2017 us-gaap Income Tax Reconciliation Income Tax Expense Benefit At Federal Statutory Income Tax Rate
IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate
-10000
CY2018 us-gaap Income Tax Reconciliation Nondeductible Expense
IncomeTaxReconciliationNondeductibleExpense
-91000
CY2017 us-gaap Income Tax Reconciliation Nondeductible Expense
IncomeTaxReconciliationNondeductibleExpense
11000
CY2018 us-gaap Income Tax Reconciliation Other Adjustments
IncomeTaxReconciliationOtherAdjustments
1000
CY2017 us-gaap Income Tax Reconciliation Other Adjustments
IncomeTaxReconciliationOtherAdjustments
CY2018 us-gaap Income Tax Reconciliation Prior Year Income Taxes
IncomeTaxReconciliationPriorYearIncomeTaxes
3000
CY2017 us-gaap Income Tax Reconciliation Prior Year Income Taxes
IncomeTaxReconciliationPriorYearIncomeTaxes
CY2018 us-gaap Income Tax Reconciliation State And Local Income Taxes
IncomeTaxReconciliationStateAndLocalIncomeTaxes
57000
CY2017 us-gaap Income Tax Reconciliation State And Local Income Taxes
IncomeTaxReconciliationStateAndLocalIncomeTaxes
1000
CY2018 us-gaap Income Taxes Paid
IncomeTaxesPaid
CY2017 us-gaap Income Taxes Paid
IncomeTaxesPaid
CY2018 us-gaap Increase Decrease In Accounts Payable And Accrued Liabilities
IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
421000
CY2017 us-gaap Increase Decrease In Accounts Payable And Accrued Liabilities
IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
291000
CY2018 us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
1005000
CY2017 us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
217000
CY2018 us-gaap Increase Decrease In Contract With Customer Asset
IncreaseDecreaseInContractWithCustomerAsset
1005000
CY2017 us-gaap Increase Decrease In Contract With Customer Asset
IncreaseDecreaseInContractWithCustomerAsset
217000
CY2018 us-gaap Increase Decrease In Deferred Revenue
IncreaseDecreaseInDeferredRevenue
598000
CY2017 us-gaap Increase Decrease In Deferred Revenue
IncreaseDecreaseInDeferredRevenue
11000
CY2018 us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
-15000
CY2017 us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
-30000
CY2018 us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
2000
CY2017 us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
14000
CY2018 us-gaap Interest Income Expense Nonoperating Net
InterestIncomeExpenseNonoperatingNet
-189000
CY2017 us-gaap Interest Income Expense Nonoperating Net
InterestIncomeExpenseNonoperatingNet
-209000
CY2018 us-gaap Interest Paid Net
InterestPaidNet
3000
CY2017 us-gaap Interest Paid Net
InterestPaidNet
6000
CY2018Q4 us-gaap Interest Payable Current
InterestPayableCurrent
479000
CY2017Q4 us-gaap Interest Payable Current
InterestPayableCurrent
348000
CY2018Q4 us-gaap Interest Payable Current And Noncurrent
InterestPayableCurrentAndNoncurrent
6000
CY2018Q4 us-gaap Inventory Net
InventoryNet
CY2017Q4 us-gaap Inventory Net
InventoryNet
15000
CY2018Q4 us-gaap Leasehold Improvements Gross
LeaseholdImprovementsGross
63000
CY2017Q4 us-gaap Leasehold Improvements Gross
LeaseholdImprovementsGross
55000
CY2018Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
4069000
CY2017Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
1452000
CY2018Q4 us-gaap Liabilities Current
LiabilitiesCurrent
3252000
CY2017Q4 us-gaap Liabilities Current
LiabilitiesCurrent
2079000
CY2018Q4 us-gaap Machinery And Equipment Gross
MachineryAndEquipmentGross
2043000
CY2017Q4 us-gaap Machinery And Equipment Gross
MachineryAndEquipmentGross
1721000
CY2018 us-gaap Nature Of Operations
NatureOfOperations
<div style="display: inline; font-family: times new roman; font-size: 10pt"><div style=" font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:left;"><div style="display: inline; font-weight: bold;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">1.</div> Description of Business</div></div> <div style=" font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:left;">&nbsp;</div> <div style=" font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:left;text-indent:36pt;">We develop, market, and support a family of entity identification, data mining, regulated information compliance and data privacy protection. Our product families include: TraceCop for identity identification, Savant for data mining and advanced persistent threat detection and Compliance Commander for regulated information and data privacy protection. Intrusion&#x2019;s products help protect critical information assets by quickly detecting, protecting, analyzing and reporting attacks or misuse of classified, private and regulated information for government and enterprise networks.</div> <div style=" font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:left;">&nbsp;</div> <div style=" font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:left;text-indent:36pt;">We market and distribute our products through a direct sales force to end-users, distributors and numerous system integrators, managed service providers and value-added resellers. Our end-user customers include banks, credit unions, other financial institutions, U.S. federal government entities, foreign government entities, hospitals and other healthcare providers. Essentially, our end-users can be defined as end-users requiring network security solutions for protecting their mission critical data.</div> <div style=" font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:left;">&nbsp;</div> <div style=" font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:left;text-indent:36pt;">References to the &#x201c;Company&#x201d;, &#x201c;we&#x201d;, &#x201c;us&#x201d;, &#x201c;our&#x201d;, &#x201c;Intrusion&#x201d; or &#x201c;Intrusion&nbsp;Inc.&#x201d; refer to Intrusion&nbsp;Inc. and its subsidiaries. Compliance Commander&#x2122; and TraceCop&#x2122; are registered trademarks of Intrusion Inc.</div> <div style=" font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:left;">&nbsp;</div> <div style=" font-family:'Times New Roman', Times, serif;font-size:10pt;margin-bottom:0pt;margin-left:0pt;margin-right:7.5pt;margin-top:0pt;text-align:left;text-indent:36pt;">As of <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"> December 31, 2018, </div>we had cash and cash equivalents of approximately <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">$1,652,000,</div> up from approximately <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">$224,000</div> as of <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"> December 31, 2017. </div>We generated net income of <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">$2,287,000</div> for the year ended <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"> December 31, 2018 </div>compared to a net loss of <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">$30,000</div> for the year ended <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"> December 31, 2017. </div>The net loss in <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">2017</div> included other income of <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">928,000,</div> of which <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">$872,000</div> came from the sale of certain unused IP addresses and <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">$56,000</div> from the sale of an investment. As of <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"> February 28, 2019, </div>in addition to cash and cash equivalents, <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">$885,000</div> of funding is available from a promissory note to borrow up to <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">$2.7</div> million from G. Ward Paxton, the Company&#x2019;s Chief Executive Officer. We are obligated to make payments of accrued dividends on all our outstanding shares of preferred stock that will reduce our available cash resources. Based on projections of growth in revenue and net income in the coming quarters, and the borrowings available previously mentioned, we believe that we will have sufficient cash resources to finance our operations and expected capital expenditures through <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"> March 31, 2020. </div>We expect to fund our operations through anticipated Company profits, borrowings from the Company&#x2019;s CEO, and possibly additional investments of private equity and debt, which, if we are able to obtain, could have the effect of diluting our existing common stockholders, perhaps significantly. Any equity or debt financings, if available at all, <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"> may </div>be on terms which are <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">not</div> favorable to us and, in the case of equity financings, <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"> may </div>result in dilution to our stockholders. If our operations do <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">not</div> generate positive cash flow in the upcoming year, or if we are <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">not</div> able to obtain additional debt or equity financing on terms and conditions acceptable to us, if at all, we <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"> may </div>be unable to implement our business plan, fund our liquidity needs or even continue our operations.</div></div>
CY2018 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
-948000
CY2017 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
-148000
CY2018 us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-202000
CY2017 us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
36000
CY2018 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
2578000
CY2017 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
272000
CY2018 us-gaap Net Income Loss
NetIncomeLoss
2287000
CY2017 us-gaap Net Income Loss
NetIncomeLoss
-30000
CY2018 us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
2148000
CY2017 us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
-169000
CY2018Q4 us-gaap Notes Payable Related Parties Noncurrent
NotesPayableRelatedPartiesNoncurrent
1815000
CY2017Q4 us-gaap Notes Payable Related Parties Noncurrent
NotesPayableRelatedPartiesNoncurrent
2865000
CY2018 us-gaap Operating Income Loss
OperatingIncomeLoss
2476000
CY2017 us-gaap Operating Income Loss
OperatingIncomeLoss
-749000
CY2018Q4 us-gaap Operating Leases Future Minimum Payments Due
OperatingLeasesFutureMinimumPaymentsDue
2096000
CY2018Q4 us-gaap Operating Leases Future Minimum Payments Due Current
OperatingLeasesFutureMinimumPaymentsDueCurrent
284000
CY2018Q4 us-gaap Operating Leases Future Minimum Payments Due In Three Years
OperatingLeasesFutureMinimumPaymentsDueInThreeYears
358000
CY2018Q4 us-gaap Operating Leases Future Minimum Payments Due In Two Years
OperatingLeasesFutureMinimumPaymentsDueInTwoYears
354000
CY2018 us-gaap Operating Leases Rent Expense Net
OperatingLeasesRentExpenseNet
316000
CY2017 us-gaap Operating Leases Rent Expense Net
OperatingLeasesRentExpenseNet
350000
CY2018Q4 us-gaap Other Accrued Liabilities Current
OtherAccruedLiabilitiesCurrent
269000
CY2017Q4 us-gaap Other Accrued Liabilities Current
OtherAccruedLiabilitiesCurrent
86000
CY2018Q4 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
38000
CY2017Q4 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
38000
CY2017 us-gaap Other Nonoperating Income
OtherNonoperatingIncome
928000
CY2018 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
CY2017 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
928000
CY2018 us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
202000
CY2017 us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
20000
CY2018 us-gaap Preferred Stock Dividends Income Statement Impact
PreferredStockDividendsIncomeStatementImpact
139000
CY2017 us-gaap Preferred Stock Dividends Income Statement Impact
PreferredStockDividendsIncomeStatementImpact
139000
CY2018Q4 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.01
CY2017Q4 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.01
CY2018Q4 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
5000000
CY2017Q4 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
5000000
CY2018Q4 us-gaap Prepaid Expense Current
PrepaidExpenseCurrent
91000
CY2017Q4 us-gaap Prepaid Expense Current
PrepaidExpenseCurrent
89000
CY2018 us-gaap Proceeds From Related Party Debt
ProceedsFromRelatedPartyDebt
150000
CY2017 us-gaap Proceeds From Related Party Debt
ProceedsFromRelatedPartyDebt
1870000
CY2017 us-gaap Proceeds From Sale Of Short Term Investments
ProceedsFromSaleOfShortTermInvestments
56000
CY2017Q3 us-gaap Proceeds From Sale Of Short Term Investments
ProceedsFromSaleOfShortTermInvestments
56000
CY2018 us-gaap Proceeds From Sale Of Short Term Investments
ProceedsFromSaleOfShortTermInvestments
CY2018 us-gaap Proceeds From Stock Options Exercised
ProceedsFromStockOptionsExercised
168000
CY2017 us-gaap Proceeds From Stock Options Exercised
ProceedsFromStockOptionsExercised
11000
CY2018Q4 us-gaap Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
2149000
CY2017Q4 us-gaap Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
1819000
CY2018Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
321000
CY2017Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
124000
CY2018 us-gaap Repayments Of Long Term Capital Lease Obligations
RepaymentsOfLongTermCapitalLeaseObligations
66000
CY2017 us-gaap Repayments Of Long Term Capital Lease Obligations
RepaymentsOfLongTermCapitalLeaseObligations
139000
CY2018 us-gaap Repayments Of Related Party Debt
RepaymentsOfRelatedPartyDebt
1200000
CY2017 us-gaap Repayments Of Related Party Debt
RepaymentsOfRelatedPartyDebt
1890000
CY2018 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
1237000
CY2017 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
2162000
CY2018Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-59242000
CY2017Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-61529000
CY2018 us-gaap Revenue From Contract With Customer Including Assessed Tax
RevenueFromContractWithCustomerIncludingAssessedTax
10276000
CY2017 us-gaap Revenue From Contract With Customer Including Assessed Tax
RevenueFromContractWithCustomerIncludingAssessedTax
6862000
CY2018 us-gaap Selling And Marketing Expense
SellingAndMarketingExpense
1604000
CY2017 us-gaap Selling And Marketing Expense
SellingAndMarketingExpense
1531000
CY2018 us-gaap Share Based Compensation
ShareBasedCompensation
20000
CY2017 us-gaap Share Based Compensation
ShareBasedCompensation
18000
CY2018 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Dividend Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate
0
CY2017 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Dividend Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate
0
CY2018 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Volatility Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate
2.2521
CY2017 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Volatility Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate
0.7546
CY2018 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Risk Free Interest Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate
0.0083
CY2017 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Risk Free Interest Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate
0.0177
CY2018Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber
1172000
CY2017Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber
1662000
CY2018Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice
0.84
CY2017Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice
0.68
CY2018 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Expirations In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpirationsInPeriod
84000
CY2017 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Expirations In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpirationsInPeriod
482000
CY2018 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod
CY2017 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod
CY2018 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Weighted Average Grant Date Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue
0.49
CY2017 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Weighted Average Grant Date Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue
0.26
CY2017Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
1746000
CY2016Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
2254000
CY2018Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
1235000
CY2017Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
0.68
CY2016Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
0.64
CY2018Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
0.83
CY2018Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Outstanding Aggregate Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAggregateIntrinsicValue
3092000
CY2018Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber
1229000
CY2018Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageExercisePrice
0.83
CY2018 us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Exercises In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice
0.37
CY2017 us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Exercises In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice
0.22
CY2018 us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Expirations In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExpirationsInPeriodWeightedAverageExercisePrice
0.22
CY2017 us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Expirations In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExpirationsInPeriodWeightedAverageExercisePrice
0.55
CY2018 us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Forfeitures In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice
CY2017 us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Forfeitures In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice
CY2018Q4 us-gaap Share Based Compensation Shares Authorized Under Stock Option Plans Exercise Price Range Number Of Exercisable Options
ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfExercisableOptions
1172000
CY2018Q4 us-gaap Share Based Compensation Shares Authorized Under Stock Option Plans Exercise Price Range Number Of Outstanding Options
ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfOutstandingOptions
1235000
CY2018 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Expiration Period
SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod
P10Y
CY2018 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Fair Value Assumptions Expected Term1
SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1
P4Y332D
CY2017 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Fair Value Assumptions Expected Term1
SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1
P5Y
CY2018Q4 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Exercisable Intrinsic Value1
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1
2940000
CY2018 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Exercisable Weighted Average Remaining Contractual Term1
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1
P2Y292D
CY2018 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Vested And Expected To Vest Outstanding Weighted Average Remaining Contractual Term1
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageRemainingContractualTerm1
P3Y25D
CY2018Q4 us-gaap Sharebased Compensation Shares Authorized Under Stock Option Plans Exercise Price Range Exercisable Options Weighted Average Exercise Price1
SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeExercisableOptionsWeightedAverageExercisePrice1
0.84
CY2018Q4 us-gaap Sharebased Compensation Shares Authorized Under Stock Option Plans Exercise Price Range Outstanding Options Weighted Average Exercise Price Beginning Balance1
SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageExercisePriceBeginningBalance1
0.83
CY2018 us-gaap Sharebased Compensation Shares Authorized Under Stock Option Plans Exercise Price Range Outstanding Options Weighted Average Remaining Contractual Term2
SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageRemainingContractualTerm2
P3Y32D
CY2018 us-gaap Stock Issued During Period Shares Stock Options Exercised
StockIssuedDuringPeriodSharesStockOptionsExercised
451000
CY2017 us-gaap Stock Issued During Period Shares Stock Options Exercised
StockIssuedDuringPeriodSharesStockOptionsExercised
50000
CY2018Q4 us-gaap Stockholders Equity
StockholdersEquity
-1062000
CY2017Q4 us-gaap Stockholders Equity
StockholdersEquity
-3509000
CY2018Q4 us-gaap Treasury Stock Shares
TreasuryStockShares
10000
CY2017Q4 us-gaap Treasury Stock Shares
TreasuryStockShares
10000
CY2018Q4 us-gaap Treasury Stock Value
TreasuryStockValue
362000
CY2017Q4 us-gaap Treasury Stock Value
TreasuryStockValue
362000
CY2018Q4 us-gaap Unrecognized Tax Benefits
UnrecognizedTaxBenefits
0
CY2017Q4 us-gaap Unrecognized Tax Benefits
UnrecognizedTaxBenefits
0
CY2018 us-gaap Use Of Estimates
UseOfEstimates
<div style="display: inline; font-family: times new roman; font-size: 10pt"><div style="display: inline; font-family: times new roman; font-size: 10pt"><div style="display: inline; font-family: times new roman; font-size: 10pt"><div style=" font-family:'Times New Roman', Times, serif;font-size:10pt;margin-bottom:0pt;margin-left:36pt;margin-right:0pt;margin-top:0pt;text-align:left;text-indent:-36pt;"><div style="display: inline; font-style: italic;"><div style="display: inline; font-weight: bold;">Use of Estimates</div></div></div> <div style=" font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:left;">&nbsp;</div> <div style=" font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:left;text-indent:36pt;">The preparation of financial statements in conformity with accounting principles generally accepted in the United States requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities at the date of the financial statements and the reported amounts of revenue and expenses during the reporting period. Estimates are used for, but <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">not</div> limited to, the accounting for doubtful accounts, sales discounts, sales returns, revenue recognition, warranty costs, inventory obsolescence, depreciation and income taxes. Actual results could differ from these estimates.</div></div></div></div>
CY2018 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
15063000
CY2017 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
12836000
CY2018 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
13049000
CY2017 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
12836000

Files In Submission

Name View Source Status
0001437749-19-005894-index-headers.html Edgar Link pending
0001437749-19-005894-index.html Edgar Link pending
0001437749-19-005894.txt Edgar Link pending
0001437749-19-005894-xbrl.zip Edgar Link pending
ex_138569.htm Edgar Link pending
ex_138570.htm Edgar Link pending
ex_138580.htm Edgar Link pending
ex_138581.htm Edgar Link pending
ex_138582.htm Edgar Link pending
ex_138584.htm Edgar Link pending
ex_138585.htm Edgar Link pending
ex_138586.htm Edgar Link pending
ex_138587.htm Edgar Link pending
ex_138588.htm Edgar Link pending
ex_138589.htm Edgar Link pending
ex_138590.htm Edgar Link pending
FilingSummary.xml Edgar Link unprocessable
Financial_Report.xlsx Edgar Link pending
intz-20181231.xml Edgar Link completed
intz-20181231.xsd Edgar Link pending
intz-20181231_cal.xml Edgar Link unprocessable
intz-20181231_def.xml Edgar Link unprocessable
intz-20181231_lab.xml Edgar Link unprocessable
intz-20181231_pre.xml Edgar Link unprocessable
intz20181231_10k.htm Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R31.htm Edgar Link pending
R32.htm Edgar Link pending
R33.htm Edgar Link pending
R34.htm Edgar Link pending
R35.htm Edgar Link pending
R36.htm Edgar Link pending
R37.htm Edgar Link pending
R38.htm Edgar Link pending
R39.htm Edgar Link pending
R4.htm Edgar Link pending
R40.htm Edgar Link pending
R41.htm Edgar Link pending
R42.htm Edgar Link pending
R43.htm Edgar Link pending
R44.htm Edgar Link pending
R45.htm Edgar Link pending
R46.htm Edgar Link pending
R47.htm Edgar Link pending
R5.htm Edgar Link pending
R6.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending